Aurobindo Pharma Limited Unit lX

FDA inspection history across 2 sites, 2019 to 2022

2
Form 483s

Every document, by year

  • Form 483

2019: one Form 483; 2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One Form 483, at Sangareddy, India.
  2. 2019The longest 483 on file: 5 observations over 7 pages at Sangareddy, India.
  3. 2022One Form 483, at Hatnoora Mandal Sangareddy, India.

Cited most

Across all Aurobindo Pharma Limited Unit lX observations on file

The complete Aurobindo Pharma Limited Unit lX file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2022-11-18483 Form 483$99
2019-02-02483 Form 483$99

Investigators on these documents

Arsen Karapetyan (1)Lata Mathew (1)

FEI number 3006370489 · most recent document Nov 18, 2022

About Aurobindo Pharma Limited Unit lX

How many FDA Form 483s has Aurobindo Pharma Limited Unit lX received?

FDA Intel has 2 Form 483s on file for Aurobindo Pharma Limited Unit lX; the most recent is dated Nov 18, 2022.

When was Aurobindo Pharma Limited Unit lX last inspected by FDA?

The most recent FDA inspection document on file for Aurobindo Pharma Limited Unit lX is a Form 483 dated Nov 18, 2022, for the site in Hatnoora Mandal Sangareddy, India.

What did FDA cite at Aurobindo Pharma Limited Unit lX?

The regulations cited most in the observations on file for Aurobindo Pharma Limited Unit lX are 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.160 (General requirements), 1 time.